Foghorn Therapeutics (FHTX) EPS (Basic) (2019 - 2026)
Foghorn Therapeutics' (FHTX) quarterly EPS (Basic) came in at -$1.16 in Q1 2026, down 217.11% year-on-year from $0.99 in Q1 2025, and down 206.24% quarter-over-quarter from -$0.38 in Q4 2025.
Foghorn Therapeutics (FHTX) EPS (Basic) (2019 - 2026) Analysis & Trends
Foghorn Therapeutics' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$1.16 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 217.11% year-over-year to -$1.16 in Q1 2026; TTM through Mar 2026 was -$3.25, a 141.5% decrease from a year earlier, with the FY2025 full-year figure at -$4.21, down 166.96% from the prior year.
- EPS (Basic) eased to -$1.16 in Q1 2026 per FHTX's latest filing, from -$0.38 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.31 in Q3 2024 and bottomed at -$1.27 in Q2 2025.
- The 5-year median for EPS (Basic) is -$0.62 (2022), against an average of -$0.62.
- Across the five-year window, EPS (Basic) jumped 77.21% in 2022 and slumped 217.11% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$0.69 in 2022, then advanced by 17.31% to -$0.57 in 2023, then surged by 38.14% to -$0.36 in 2024, then decreased by 6.59% to -$0.38 in 2025, then plunged by 206.24% to -$1.16 in 2026.
- Per Business Quant, the three latest FHTX EPS (Basic) figures stand at -$1.16 (Q1 2026), -$0.38 (Q4 2025), and -$0.66 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Foghorn Therapeutics | 352.57 Mn | 263.66 Mn | - | -1.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.16 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -0.66 |
| Jun 30, 2025 | -1.27 |
| Mar 31, 2025 | -0.37 |
| Dec 31, 2024 | -0.36 |
| Sep 30, 2024 | -0.31 |
| Jun 30, 2024 | -0.45 |
| Mar 31, 2024 | -0.59 |
| Dec 31, 2023 | -0.57 |
| Sep 30, 2023 | -0.34 |
| Jun 30, 2023 | -0.70 |
| Mar 31, 2023 | -0.73 |
| Dec 31, 2022 | -0.69 |
| Sep 30, 2022 | -0.62 |
| Jun 30, 2022 | -0.66 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | -0.98 |
| Sep 30, 2021 | -2.71 |
| Jun 30, 2021 | -2.71 |